Ellerston Asia Growth Fund

The Fund is an actively managed, concentrated portfolio of Asia ex-Japan listed companies that is benchmark independent and has a focus on capital growth and downside protection.

  • High quality portfolio of 20-50 high quality, high growth, large cap Asian companies.
  • Managed by team of dedicated Asia specialists who have diverse sector and geographic expertise and extensive on the ground investment experience.
  • Distinctive high conviction, benchmark independent approach.
  • Blends macro insights with investable long-term themes and company analysis within a highly disciplined, repeatable investment process.
  • Unique, proprietary and multi-step approach to ESG that is embedded throughout the investment process and is measured against the benchmark.
  • Significant harm sectors including controversial weapons and tobacco are screened out as are other sectors including like nuclear energy, coal, palm oil production, gambling and pornography.

Exposure to strong companies in the world’s fastest growing region


The Fund’s objective is to outperform the MSCI Asia Ex Japan (non-accumulation) (AUD) benchmark on a net of fees basis, with a focus on capital growth and downside protection. Mary Manning and her team aim to generate positive returns and minimise negative returns by investing in companies in which they have the highest conviction. They filter the investment universe repeatedly to identify those companies that are likely to offer the best risk/reward profile, then assess them in detail through disciplined, ‘bottom up’ fundamental analysis and overlay that with their identified structural themes driving growth in Asia in order to construct the portfolio.

+ Disclaimer and Notes

DISCLAIMER: Ellerston Capital Limited ABN 34 110 397 674 AFSL 283000 is the responsible entity and issuer of units in the Ellerston Asia Growth Fund ARSN 626 690 686. Any information is general and does not take into account your personal objectives, financial situation or needs. Accordingly you should consider the Product Disclosure Statement before deciding whether to acquire or continue to hold units in the Fund available from this website or by contacting us on 9021 7797.